Skip to main content

INDRE Investigation Lines

Identification of risk variants in non-coding regions in epileptic encephalopathies.The human brain evolution has been accelerated since we diverged from apes. Using comparative genomics we have identified non-coding regions in the genome with a high prevalence of epilepsy risk variants. Using comparative genomics in humans , we are workin gin the design of a better platform to advance towards better genetic diagnostic of epileptic encephalopathies, especially in those refractory to drug treatments.

iPSC models -an step towards personalized medecine One of the biggest burdens of the human brain is the lack of reliable models for many of the disease functions. iPSC-derived organoids can overcome many of these caveats. Using patient derived iPSC and/or CRISPR engineering in iPSC we model the neuronal function and we move towards a personalize medecine approach.

sandra acosta

Sandra Acosta

Dept of Experimental Science and Health, Universitat Pompeu Fabra

Sandra.acosta@upf.edu

 

Institution

DCEXS-UPF, Dept of Experimental Science and Health, Universitat Pompeu Fabra

Plaça de la Mercè, 10, 08002 Barcelona

Publications

Staff

Andrea Martí (starting October 2019)

Areas of investigation

Identification of risk variants in non-coding regions in epileptic encephalopathies

iPSC models -an step towards personalized medecine

The Apoyodravet Association (AD) central pillars are social innovation, patient-oriented technology and the promotion of research in the service of disease modification.

If you want to stay updated on the INDRE international research network please...